17.10.2014 - Jarrod Longcor the former Vice President of Corporate Development for Rib-X Pharmaceuticals has been appointed CBO at Avillion LLP.
Jarrod Longcor brings over 18 years of pharmaceutical and biotech experience to the London-based drug development company. In his previous role at Rib-X Pharmaceuticals, Inc (now Melinta Therapeutics), Longcor was responsible for identifying and concluding several critical collaborations for the company. Prior to Rib-X, he held key positions in several small to mid-sized biotech companies where he was responsible for business development and strategic planning. At Avillion, Longcor will be responsible for structuring, negotiating and executing strategic alliances, co-development agreements, and financial instruments, as well as providing management and strategic leadership to the organisation.http://www.european-biotechnology-news.com/people/bio-people/2014/jarrod-longcor.html